Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications

Stephanie L. Harrison; Benjamin J. R. Buckley; Deirdre A. Lane; Paula Underhill; Professor Gregory Lip

doi:10.1016/j.phrs.2021.105534

Related publications

Article2020

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19

Stephanie L. Harrison, Elnara Fazio‐Eynullayeva, Deirdre A. Lane, Paula Underhill, Professor Gregory Lip

Article2020

End-Stage renal disease and 30-day mortality for adults with and without COVID-19

Stephanie L. Harrison, Benjamin J. R. Buckley, Elnara Fazio‐Eynullayeva, Paula Underhill, Deirdre A. Lane, Professor Gregory Lip

Article2021

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

José Miguel Rivera‐Caravaca, Benjamin J. R. Buckley, Stephanie L. Harrison, Elnara Fazio‐Eynullayeva, Paula Underhill, Francisco Marı́n, Professor Gregory Lip

Article2021

Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19

Juan Caro‐Codón, Professor Gregory Lip, Juan R. Rey, Ángel Manuel Iniesta, Sandra Rosillo, Sergio Castrejón‐Castrejón, Laura Rodríguez‐Sotelo, Jose M. García‐Veas, Irene Marco Clement, Luis A. Martinez, Lorena Martín‐Polo, Carlos Merino, Marcel Martínez‐Cossiani, Antonio Buño Soto, Luis Gonzalez‐Valle, Alicia Herrero, Esteban López de Sá, José Luís Merino

Article2021

Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19

Rafael Díaz, Andrés Orlandini, Noelia Castellana, Alberto Caccavo, Pablo Corral, Gonzalo Corral, Carolina Chacón, Pablo Lamelas, Fernando Botto, Marı́a Luz Dı́az, Juan Manuel Domı́nguez, Andrea Pascual, Carla Rovito, Agustina Galatte, Franco Scarafia, Omar Sued, Omar Gutiérrez, Sanjit S. Jolly, José M Miró, John W. Eikelboom, Mark Loeb, Aldo Maggioni, Deepak L. Bhatt,

Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications

Discussion(0)

Related publications

Atrial fibrillation and the risk of 30‐day incident thromboembolic events, and mortality in adults ≥ 50 years with COVID‐19

End-Stage renal disease and 30-day mortality for adults with and without COVID-19

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19

Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19